Klaus Charisse Alnylam Pharmaceuticals, Inc. Biography Publications Institution JoVE Articles Klaus Charisse has not added a biography. If you are Klaus Charisse and would like to personalize this page please email our Author Liaison for assistance. Publications Molecularly Self-assembled Nucleic Acid Nanoparticles for Targeted in Vivo SiRNA Delivery Nature Nanotechnology. 2012 | Pubmed ID: 22659608 RNA (New York, N.Y.). Mar, 2012 | Pubmed ID: 22294662 Experimental Neurology. Jan, 2012 | Pubmed ID: 22119622 Angewandte Chemie (International Ed. in English). Mar, 2011 | Pubmed ID: 21351337 The Journal of Organic Chemistry. Mar, 2011 | Pubmed ID: 21299239 Nucleic Acids Research. Nov, 2010 | Pubmed ID: 20610434 Nucleic Acids Research. Aug, 2010 | Pubmed ID: 20403811 Analytical Biochemistry. Jun, 2010 | Pubmed ID: 20156415 Oligonucleotides. Mar, 2009 | Pubmed ID: 19093781 Molecular Neurodegeneration. 2008 | Pubmed ID: 18976489 ARNi Terapéutico Dirigidos a PCSK9 Agudo Disminuye El Colesterol Plasmático En Roedores Y El Colesterol LDL En Primates No Humanos Proceedings of the National Academy of Sciences of the United States of America. Aug, 2008 | Pubmed ID: 18695239 Nature. Nov, 2004 | Pubmed ID: 15538359 Un modelo de tumor vesical ortotópica y la Evaluación de tratamiento intravesical SARNA Moo Rim Kang*1, Glen Yang*1, Klaus Charisse2, Hila Epstein-Barash2, Muthiah Manoharan2, Long-Cheng Li1 1Department of Urology and Helen Diller Comprehensive Cancer Center, University of California, San Francisco, 2Alnylam Pharmaceuticals, Inc. JoVE 4207 Medicine
Un modelo de tumor vesical ortotópica y la Evaluación de tratamiento intravesical SARNA Moo Rim Kang*1, Glen Yang*1, Klaus Charisse2, Hila Epstein-Barash2, Muthiah Manoharan2, Long-Cheng Li1 1Department of Urology and Helen Diller Comprehensive Cancer Center, University of California, San Francisco, 2Alnylam Pharmaceuticals, Inc. JoVE 4207 Medicine